The Use of ADV6209 for Premedication in Pediatric Anesthesia
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of ADV6209, a new oral Midazolam formulation, on preoperative anxiety
and sedation levels in paediatric anaesthesia Primary Objective: Sedation score (mYPAS) 30
min after administration of the premedication drug Secondary Objective: Acceptance of
anaesthesia mask induction Acceptance of oral administration of the premedication drug